2009
DOI: 10.1186/1477-9560-7-9
|View full text |Cite
|
Sign up to set email alerts
|

Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores)

Abstract: The present study demonstrated, for the first time, that São Miguel, and possibly the Azores population, shows significant differences on allele frequencies of thrombotic risk factors when compared to mainland Portugal. This research constitutes a primary approach for future studies on CVD, as well as for the implementation of warfarin dosing protocols using the patient's genotypic information.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
1

Year Published

2011
2011
2016
2016

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 41 publications
0
4
1
Order By: Relevance
“…In a previous study of three thrombotic risk loci in São Miguel Island (Azores), Branco and collaborators [36] found individuals with the F2 GA-MTHFR TT to represent only 0.4% of their sample while in our study this value was 3-fold higher (1.3%). On the other hand, only 0.6% of our subjects were F5 GA-MTHFR TT, as compared to 3.2% observed by Branco et al [36].…”
Section: Discussioncontrasting
confidence: 66%
See 1 more Smart Citation
“…In a previous study of three thrombotic risk loci in São Miguel Island (Azores), Branco and collaborators [36] found individuals with the F2 GA-MTHFR TT to represent only 0.4% of their sample while in our study this value was 3-fold higher (1.3%). On the other hand, only 0.6% of our subjects were F5 GA-MTHFR TT, as compared to 3.2% observed by Branco et al [36].…”
Section: Discussioncontrasting
confidence: 66%
“…Homozygosity or compound heterozygosity for the F5 and F2 risk alleles, as well as the presence of these mutations combined with the MTHFR 677TT genotype, were shown to be associated with a highly significant increase of the odds of presenting VTE [35]. In a previous study of three thrombotic risk loci in São Miguel Island (Azores), Branco and collaborators [36] found individuals with the F2 GA-MTHFR TT to represent only 0.4% of their sample while in our study this value was 3-fold higher (1.3%). On the other hand, only 0.6% of our subjects were F5 GA-MTHFR TT, as compared to 3.2% observed by Branco et al [36].…”
Section: Discussionmentioning
confidence: 94%
“…An MTHFR C677T-CT variant of the gene was identified. Although associated with an increased level of homocysteinemia in carriers, an allelic frequency of 41.68% has been reported in our resident population [ 8 ].…”
Section: Clinical Casementioning
confidence: 73%
“…According to some studies, MTHFR activity falls by 40–50% and a biochemical profile similar to that in homozygous carriers of the 677T allele is observed in compound heterozygous individuals [ 33 ]. The lowest frequency of the 1298C allele was detected in residents of Senegal (4%), whereas the highest frequency was detected in the Israeli and New Guinean populations (41%) [ 34 , 35 ]. In Russians, the frequency of this allele varies from 24 to 38% [ 31 ].…”
Section: Resultsmentioning
confidence: 99%